Role of Alpha Blockers in Hypertension with Benign Prostatic Hyperplasia.

Abstract

Hypertension and benign prostatic hyperplasia (BPH) are common disorders of aging men. As the world population is aging these two diseases are becoming a significant public health problem worldwide. Approximately 30% of men treated for BPH have coexisting hypertension. The α-Adrenergic Blockers: Prazosin, Terazosin and Doxazosin are established agents in the therapy of hypertension, and are also effective drugs in the treatment of BPH. It is reasonable to use α-Adrenergic Blockers as the treatment of choice for men with hypertension and BPH.

• Authors: R P Mathur, Sumanlata Nayak, R Sivaramakrishnan, Vikas Jain
• Journal: The Journal of the Association of Physicians of India (J Assoc Physicians India) Vol. 62 Issue 9 Suppl Pg. 40-4 (Sep 2014) ISSN: 0004-5772 [Print] India
• PMID: 26245042 (Publication Type: Journal Article)

Chemical References

• Adrenergic alpha-Antagonists
• Antihypertensive Agents

Topics

• Adrenergic alpha-Antagonists (adverse effects, therapeutic use)
• Antihypertensive Agents (adverse effects, therapeutic use)
• Autonomic Nervous System (physiopathology)
• Humans
• Hypertension (complications, drug therapy, epidemiology, physiopathology)
• Male
• Prostatic Hyperplasia (complications, epidemiology, physiopathology)